Tibet AIM Pharm. Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 726.72 million compared to CNY 602.62 million a year ago. Net income was CNY 44.96 million compared to CNY 41.09 million a year ago. Basic earnings per share from continuing operations was CNY 0.24 compared to CNY 0.22 a year ago.